American Nutrition Association Partners with Jazz Pharmaceuticals to Promote Evidence-Based Sodium Reduction and Cardiovascular Health Education

The American Nutrition Association (ANA) has partnered with Jazz Pharmaceuticals to provide evidence-based nutritional education to individuals with narcolepsy or idiopathic hypersomnia, who have a higher risk of cardiovascular and cardiometabolic comorbidities. The initiative aims to empower patients and clinicians with actionable guidance for sodium reduction and cardiovascular health education. Excess sodium intake is a modifiable risk factor for hypertension and cardiovascular disease, and the ANA aims to translate nutrition science into actionable guidance for this patient population.